CME Group stock falls 3.07 percent: JPMorgan targets USD 367.00
Published on 10/27/2026 at 16:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and trading move
- JPMorgan upgraded CME Group to Overweight and set a USD 367.00 target on October 22, 2026.
- CME Group reported USD 1.737 billion in third-quarter 2026 revenue versus USD 1.538 billion a year earlier.
- CME Group stock costs EUR 268.30 at Lang & Schwarz on October 27, 2026 at 4:09 p.m. CEST, while Nasdaq trading was down 3.07 percent.
CME Group Inc. (ISIN US12572Q1058) stock fell 3.07 percent on Nasdaq to USD 298.59 on October 27, 2026, versus the prior close of USD 308.06 on October 26, 2026. The move follows a week of analyst actions after the exchange operator's third-quarter report, with JPMorgan upgrading the stock and setting a USD 367.00 target on October 22, 2026, as MarketScreener reported. At Lang & Schwarz, the euro quote was EUR 268.30 on October 27, 2026 at 4:09 p.m. CEST.
Q3 revenue reaches USD 1.737 billion
CME Group reported third-quarter 2026 revenue of USD 1.737 billion, up from USD 1.538 billion in the third quarter of 2025. The company also reported operating income of USD 1.141 billion and net income of USD 1.037 billion for the quarter ended September 30, 2026. The figures came from the company's release dated October 21, 2026, published on CME Group.
Trading activity supplied the operating backdrop. Average daily volume reached 29.4 million contracts in the third quarter of 2026, a record for that quarter, while market data revenue rose 20 percent year over year to USD 243.1 million. Adjusted diluted earnings per share were USD 3.02, compared with USD 2.68 in the third quarter of 2025.
What does USD 367 imply?
JPMorgan's USD 367.00 target is 22.91 percent above the Nasdaq price of USD 298.59 on October 27, 2026. UBS raised its target from USD 270.00 to USD 310.00 on October 22, 2026 while retaining a Neutral rating, according to Markets Insider. The two targets leave a wide spread in the current analyst debate.
Valuation and next reporting date
CME Group had a market capitalization of USD 107.4 billion and a price-to-earnings ratio of 24.50 as of October 27, 2026. Its 52-week range was USD 218.31 to USD 329.16, placing the Nasdaq price 9.29 percent below the high. The next earnings release is expected on February 3, 2027, according to Zacks.
Price position for CME Group
The Nasdaq move puts the stock below its October 26, 2026 close, while the euro quote remains the relevant German trading indication for this report. CME Group's third-quarter revenue growth and record contract volume provide the operating figures against which the analyst targets are being assessed.
CME Group stock was trading at EUR 268.30 at Lang & Schwarz on October 27, 2026 at 4:09 p.m. CEST. Nasdaq trading was down 3.07 percent versus the prior close of October 26, 2026. The further course of trading is shown by the continuously updated real-time quote of CME Group stock.
CME Group stock at a glance
- Company: CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 27, 2026, 4:09 p.m. CEST): EUR 268.30
- Change on Nasdaq versus prior close: minus 3.07 percent
- Prior close on Nasdaq (October 26, 2026): USD 308.06
- Market capitalization: USD 107.4 billion (as of October 27, 2026)
- 52-week range: USD 218.31-USD 329.16 (as of October 27, 2026)
- Sector / Industry: Financial Services / Financial - Data and Stock Exchanges
Market context: Market report Nasdaq Composite.
